Hainan Hospital of Chinese PLA General Hospital
Welcome,         Profile    Billing    Logout  
 10 Trials 
4 Trials

   Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Wang, Lu
NCT05673824: Effect of Huaier Granule on Nephrotoxicity Associated With Targeted Therapy for Advanced Hepatobiliary Malignancies.

Recruiting
4
53
RoW
Huaier Granule, VEGFR-TKIs
Fudan University, LinkDoc Technology (Beijing) Co. Ltd.
Nephrotoxicity
02/25
04/25
NCT05396937: Efficacy and Safety of T+A+RAD in HCC

Recruiting
2
42
RoW
Multifocal Stereotactic Radiotherapy, Atezolizumab Injection [Tecentriq], Bevacizumab
Fudan University, Roche Pharma AG
Hepatocellular Carcinoma
12/23
12/23
Xu, Yuanyuan
NCT05632861: HuHuangLianzonggan Capsule in Subjects With Nonalcoholic Steatohepatitis: a Phase 2 tRial(HHL-HEPAR)

Recruiting
2
76
RoW
HuHuangLianzonggan capsule, Experimental group, HuHuangLianzonggan capsule placebo, Placebo group
Tasly Pharmaceutical Group Co., Ltd
NASH
12/24
12/24
Zhao, Ya-Li
NCT05224960: Human Umbilical Cord-derived Mesenchymal Stem Cells for Decompensated Cirrhosis (MSC-DLC-2)

Recruiting
2
140
RoW
UC-MSCs, Placebo(solution without UC-MSCs)
Beijing 302 Hospital, Chinese PLA General Hospital, Shanghai Changzheng Hospital, LanZhou University, Jin Yin-tan Hospital, Hainan Hospital of Chinese PLA General Hospital, Vcanbio Cell and Gene Engineering Corp., Ltd., Third Affiliated Hospital, Sun Yat-Sen University, Xinjiang Kashi Area Number 1 Hospital
Decompensated Cirrhosis
06/25
06/27
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Wang, Lu
NCT05673824: Effect of Huaier Granule on Nephrotoxicity Associated With Targeted Therapy for Advanced Hepatobiliary Malignancies.

Recruiting
4
53
RoW
Huaier Granule, VEGFR-TKIs
Fudan University, LinkDoc Technology (Beijing) Co. Ltd.
Nephrotoxicity
02/25
04/25
NCT05396937: Efficacy and Safety of T+A+RAD in HCC

Recruiting
2
42
RoW
Multifocal Stereotactic Radiotherapy, Atezolizumab Injection [Tecentriq], Bevacizumab
Fudan University, Roche Pharma AG
Hepatocellular Carcinoma
12/23
12/23
Xu, Yuanyuan
NCT05632861: HuHuangLianzonggan Capsule in Subjects With Nonalcoholic Steatohepatitis: a Phase 2 tRial(HHL-HEPAR)

Recruiting
2
76
RoW
HuHuangLianzonggan capsule, Experimental group, HuHuangLianzonggan capsule placebo, Placebo group
Tasly Pharmaceutical Group Co., Ltd
NASH
12/24
12/24
Zhao, Ya-Li
NCT05224960: Human Umbilical Cord-derived Mesenchymal Stem Cells for Decompensated Cirrhosis (MSC-DLC-2)

Recruiting
2
140
RoW
UC-MSCs, Placebo(solution without UC-MSCs)
Beijing 302 Hospital, Chinese PLA General Hospital, Shanghai Changzheng Hospital, LanZhou University, Jin Yin-tan Hospital, Hainan Hospital of Chinese PLA General Hospital, Vcanbio Cell and Gene Engineering Corp., Ltd., Third Affiliated Hospital, Sun Yat-Sen University, Xinjiang Kashi Area Number 1 Hospital
Decompensated Cirrhosis
06/25
06/27

Download Options